Roles for VEGF in the adult

被引:154
作者
Maharaj, Arindel S. R.
D'Amore, Patricia A.
机构
[1] Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA
关键词
VEGF; angiogenesis; preeclampsia; anti-angiogenic therapy; bevacizumab; endothelial cells; avastin; fenestrations;
D O I
10.1016/j.mvr.2007.03.004
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease precclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies. Published by Elsevier Inc.
引用
收藏
页码:100 / 113
页数:14
相关论文
共 188 条
  • [1] Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and-2 suggests an important role of astrocytes in cerebellar vascularization
    Acker, T
    Beck, H
    Plate, KH
    [J]. MECHANISMS OF DEVELOPMENT, 2001, 108 (1-2) : 45 - 57
  • [2] Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer
    Allen, Jeffrey A.
    Adlakha, Ashish
    Bergethon, Peter R.
    [J]. ARCHIVES OF NEUROLOGY, 2006, 63 (10) : 1475 - 1478
  • [3] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [4] Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier
    Ambati, Balamurali K.
    Patterson, Emory
    Jani, Pooja
    Jenkins, Crystal
    Higgins, Eric
    Singh, Nirbhai
    Suthar, Tushar
    Vira, Nehali
    Smith, Kimberly
    Caldwell, Ruth
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (04) : 505 - 508
  • [5] Corneal avascularity is due to soluble VEGF receptor-1
    Ambati, Balamurali K.
    Nozaki, Miho
    Singh, Nirbhai
    Takeda, Atsunobu
    Jani, Pooja D.
    Suthar, Tushar
    Albuquerque, Romulo J. C.
    Richter, Elizabeth
    Sakurai, Eiji
    Newcomb, Michael T.
    Kleinman, Mark E.
    Caldwell, Ruth B.
    Lin, Qing
    Ogura, Yuichiro
    Orecchia, Angela
    Samuelson, Don A.
    Agnew, Dalen W.
    St. Leger, Judy
    Green, W. Richard
    Mahasreshti, Parameshwar J.
    Curiel, David T.
    Kwan, Donna
    Marsh, Helene
    Ikeda, Sakae
    Leiper, Lucy J.
    Collinson, J. Martin
    Bogdanovich, Sasha
    Khurana, Tejvir S.
    Shibuya, Masabumi
    Baldwin, Megan E.
    Ferrara, Napoleone
    Gerber, Hans-Peter
    De Falco, Sandro
    Witta, Jassir
    Baffi, Judit Z.
    Raisler, Brian J.
    Ambati, Jayakrishna
    [J]. NATURE, 2006, 443 (7114) : 993 - 997
  • [6] Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells -: Comparison of the effects of heparin and modified heparins
    Ashikari- Hada, S
    Habuchi, H
    Kariya, Y
    Kimata, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (36) : 31508 - 31515
  • [7] VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
    Azzouz, M
    Ralph, GS
    Storkebaum, E
    Walmsley, LE
    Mitrophanous, KA
    Kingsman, SM
    Carmeliet, P
    Mazarakis, ND
    [J]. NATURE, 2004, 429 (6990) : 413 - 417
  • [8] Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules
    Baffert, F
    Le, T
    Thurston, G
    McDonald, DM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (01): : H107 - H118
  • [9] Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
    Baffert, F
    Le, T
    Sennino, B
    Thurston, G
    Kuo, CJ
    Hu-Lowe, D
    McDonald, DM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (02): : H547 - H559
  • [10] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343